drugset / Trial / NCT04360785

Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in Spondyloarthritis

NCT04360785

RandomizedParallel-groupSingle-blindPrevention

Summary

Preliminary report have demonstrated that methotrexate induces an anti bio-medicament tolerization whan administrated just before the first administration of the bio-medicament. Once this tolerization is obtained it seems useless to continue the methotrexate because this treatment has no efficacity in cases of spondyloarthritis.

Timeline

Start
2020-11-11
Primary completion
2022-09-13
Completion
2023-02-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule Subcutaneous

Indications